Bharat Immunological Biological Corporation Ltd vs Roopa Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 17.47 as of 18 May 15:30 . The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Roopa Industries Ltd changed from 10.3 on March 2021 to 19.8 on March 2025 . This represents a CAGR of 13.96% over 5 years The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 196.47 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Roopa Industries Ltd changed from ₹ 7.36 crore on March 2021 to ₹ 40.25 crore on March 2025 . This represents a CAGR of 40.47% over 5 years The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Roopa Industries Ltd for the Dec '25 is ₹ 33.54 crore as compare to the Sep '25 revenue of ₹ 28.75 crore. This represent the growth of 16.66% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Roopa Industries Ltd for the Dec '25 is ₹ 2.03 crore as compare to the Sep '25 ebitda of ₹ 1.64 crore. This represent the growth of 23.78% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Roopa Industries Ltd changed from ₹ 0.27 crore to ₹ 0.77 crore over 7 quarters. This represents a CAGR of 82.00% The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Roopa Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Roopa Industries Ltd

Roopa Industries Limited was incorporated 1985 as a Private Limited Company with the name 'Roopa Granites Private Limited', the name of the Company was changed to 'Roopa Granites Limited' in 1992 and further changed its name to M/s.
Roopa Industries in 1994.
The Company is engaged in manufacturing of Bulk drugs/Drug Intermediates. Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries.
The Company became a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998. The Company handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations.

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Roopa Industries Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Roopa Industries Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 75 Cr while Market cap of Roopa Industries Ltd is 42 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Roopa Industries Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Roopa Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Roopa Industries Ltd?

As of May 18, 2026, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.47. On the other hand, Roopa Industries Ltd stock price is INR ₹53.75.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Roopa Industries Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Roopa Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.